ZJYL Inc.
ZJYL scores 0.6 on the Conservative profile, blending a fundamental score (80% weight, emphasizing quality and stability (84% of fundamental weight)) with a machine-learning signal (20% weight) trained on 82 features across 30 years of data.
Net penalties of -29.6 points significantly impact the ranking. Without these adjustments, ZJYL would rank considerably higher.
These features are direct inputs to the machine learning model. The model was trained on these signals alongside 100 features (including 12 momentum/technical indicators) to produce the ML percentile score.
| Stock | Score | P/E | Rev Growth | Margin | Mkt Cap |
|---|---|---|---|---|---|
| ZJYL | 0.6 | 18.5 | -12.0% | 5.8% | N/A |
| CFBK | 44.5 | 11.6 | 3.1% | 13.7% | N/A |
| AIOT | 35.9 | N/A | 0.0% | -7.4% | N/A |
| STRT | 31.0 | 13.5 | 5.1% | 4.6% | $381M |
| IMNM | 30.7 | N/A | -35.5% | N/A | $2.0B |
| TECX | 29.5 | N/A | 0.0% | 0.0% | $425M |
| MRAM | 29.4 | N/A | -21.0% | -0.9% | $256M |
| GT | 24.7 | N/A | -3.2% | -9.4% | $2.4B |
| ESOA | 19.4 | 106.4 | 16.8% | 0.5% | N/A |
| UXIN | 19.1 | N/A | 45.0% | -10.7% | N/A |
| IPX | 10.0 | N/A | 0.0% | 0.0% | N/A |
| SKYX | 9.4 | N/A | 46.8% | -39.1% | N/A |
| PCT | 2.4 | N/A | 0.0% | -4036.3% | N/A |
| TDOG | 0.0 | N/A | N/A | N/A | N/A |
| TMUSZ | 0.0 | N/A | N/A | N/A | N/A |
| KBON | 0.0 | N/A | N/A | N/A | N/A |
| Sector Average | 11.0 | 37.5 | 5.6% | -547.1% | โ |
Jin Medical International Ltd. engages in the design, development, manufacturing, and sale of wheelchair and other living aids products for people with disabilities or impaired mobility in China and internationally. It also offers oxygen concentrators and bathing machines. The company was founded in 2006 and is based in Changzhou, China. Jin Medical International Ltd. is a subsidiary of Jolly Harmony Enterprises Limited.
Stock is in a downtrend below the 200-day moving average. Price is below both the 50-day and 200-day SMAs, indicating sustained selling pressure.
| Metric | Q4 2025 | Q2 2025 | Q4 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $11M | $10M | $13M | $11M |
| Gross Profit | $4M | $3M | $6M | $4M |
| Operating Income | $1M | $-454,212 | $2M | $1M |
| Net Income | $1M | $-89,008 | $2M | $2M |
| EPS (Diluted) | $0.01 | $-0.00 | $0.01 | $0.01 |
| Gross Margin | 33.7% | 25.6% | 44.9% | 36.0% |
| Operating Margin | 9.8% | -4.6% | 18.6% | 11.6% |
| Net Margin | 11.8% | -0.9% | 14.5% | 17.0% |
This stock has limited trading volume and/or float. Institutional investors may face difficulty entering or exiting positions without significant price impact. A post-hoc penalty has been applied to the composite score (this is not a backtested model factor โ it is a practical tradability overlay).
| Year | Low | High | Range | Status |
|---|---|---|---|---|
| 2023 | $0.24 | $25.49 | 196.2% | Wide |
| 2024 | $0.70 | $16.60 | 183.8% | Wide |
| 2025 | $0.18 | $1.19 | 147.2% | Wide |
Growth estimates have been dampened based on technical and fundamental signals. This is a post-hoc adjustment to prevent overly optimistic projections for stocks showing declining momentum or deteriorating fundamentals.
Scores are generated by a multi-stage ML pipeline combining fundamental analysis, ensemble predictions, and structural risk signals. All data is for research purposes only and does not constitute financial advice. Past performance does not guarantee future results.